Search

everythinglearnresearchcommunity

for

Search:↓

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

EH-MSCs may help treat hair loss by reducing inflammation.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Pregnancy increases certain GABA_A receptors in rat brains, influenced by steroid levels.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Finasteride may cause kidney damage.

Damage to skin releases dsRNA, which activates TLR3 and helps in skin and hair follicle regeneration.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.